» Articles » PMID: 38388415

SPOCK2 Modulates Neuropathic Pain by Interacting with MT1-MMP to Regulate Astrocytic MMP-2 Activation in Rats with Chronic Constriction Injury

Overview
Publisher Biomed Central
Date 2024 Feb 22
PMID 38388415
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Neuropathic pain (NP) is a kind of intractable pain. The pathogenesis of NP remains a complicated issue for pain management practitioners. SPARC/osteonectin, CWCV, and Kazal-like domains proteoglycan 2 (SPOCK2) are members of the SPOCK family that play a significant role in the development of the central nervous system. In this study, we investigated the role of SPOCK2 in the development of NP in a rat model of chronic constriction injury (CCI).

Methods: Sprague-Dawley rats were randomly grouped to establish CCI models. We examined the effects of SPOCK2 on pain hpersensitivity and spinal astrocyte activation after CCI-induced NP. Paw withdrawal threshold (PWT) and paw withdrawal latency (PWL) were used to reflects the pain behavioral degree. Molecular mechanisms involved in SPOCK2-mediated NP in vivo were examined by western blot analysis, immunofluorescence, immunohistochemistry, and co-immunoprecipitation. In addition, we examined the SPOCK2-mediated potential protein-protein interaction (PPI) in vitro coimmunoprecipitation (Co-IP) experiments.

Results: We founded the expression level of SPOCK2 in rat spinal cord was markedly increased after CCI-induced NP, while SPOCK2 downregulation could partially relieve pain caused by CCI. Our research showed that SPOCK2 expressed significantly increase in spinal astrocytes when CCI-induced NP. In addition, SPOCK2 could act as an upstream signaling molecule to regulate the activation of matrix metalloproteinase-2 (MMP-2), thus affecting astrocytic ERK1/2 activation and interleukin (IL)-1β production in the development of NP. Moreover, in vitro coimmunoprecipitation (Co-IP) experiments showed that SPOCK2 could interact with membrane-type 1 matrix metalloproteinase (MT1-MMP/MMP14) to regulate MMP-2 activation by the SPARC extracellular (SPARC_EC) domain.

Conclusions: Research shows that SPOCK2 can interact with MT1-MMP to regulate MMP-2 activation, thus affecting astrocytic ERK1/2 activation and IL-1β production to achieve positive promotion of NP.

Citing Articles

Spinal astrocytes involved in the pathogenesis and treatment of neuropathic pain.

Li X, Huang Y, Bai J Front Cell Neurosci. 2025; 19:1547524.

PMID: 40062207 PMC: 11885516. DOI: 10.3389/fncel.2025.1547524.


Unveiling the Mechanisms of Pain in Endometriosis: Comprehensive Analysis of Inflammatory Sensitization and Therapeutic Potential.

Chen Y, Li T Int J Mol Sci. 2025; 26(4).

PMID: 40004233 PMC: 11855056. DOI: 10.3390/ijms26041770.


SPOCK2 controls the proliferation and function of immature pancreatic β-cells through MMP2.

Blaszczyk K, Jedrzejak A, Ziojla N, Shcheglova E, Szarafin K, Jankowski A Exp Mol Med. 2024; 57(1):131-150.

PMID: 39741186 PMC: 11799530. DOI: 10.1038/s12276-024-01380-2.


Intervention effect of regulating GABA-A receptor activity on the formation of experimental abdominal aortic aneurysm in rats.

Zhu J, Zhou C, Huang L, Guo J, Yin N, Yang F Sci Rep. 2024; 14(1):31388.

PMID: 39732918 PMC: 11682254. DOI: 10.1038/s41598-024-82913-7.


Mechanisms and Therapeutic Prospects of Microglia-Astrocyte Interactions in Neuropathic Pain Following Spinal Cord Injury.

Liu Y, Cai X, Shi B, Mo Y, Zhang J, Luo W Mol Neurobiol. 2024; 62(4):4654-4676.

PMID: 39470872 DOI: 10.1007/s12035-024-04562-1.


References
1.
Ma W, Quirion R . Partial sciatic nerve ligation induces increase in the phosphorylation of extracellular signal-regulated kinase (ERK) and c-Jun N-terminal kinase (JNK) in astrocytes in the lumbar spinal dorsal horn and the gracile nucleus. Pain. 2002; 99(1-2):175-84. DOI: 10.1016/s0304-3959(02)00097-0. View

2.
Dai Y, Iwata K, Fukuoka T, Kondo E, Tokunaga A, Yamanaka H . Phosphorylation of extracellular signal-regulated kinase in primary afferent neurons by noxious stimuli and its involvement in peripheral sensitization. J Neurosci. 2002; 22(17):7737-45. PMC: 6757977. View

3.
Zhang L, Gao S, Sun J, Li D, Wu J, Song F . DKK3 ameliorates neuropathic pain via inhibiting ASK-1/JNK/p-38-mediated microglia polarization and neuroinflammation. J Neuroinflammation. 2022; 19(1):129. PMC: 9164405. DOI: 10.1186/s12974-022-02495-x. View

4.
Freidin M, Tsepilov Y, Palmer M, Karssen L, Suri P, Aulchenko Y . Insight into the genetic architecture of back pain and its risk factors from a study of 509,000 individuals. Pain. 2019; 160(6):1361-1373. PMC: 7066867. DOI: 10.1097/j.pain.0000000000001514. View

5.
Hong S, Remacle A, Shiryaev S, Choi W, Hullugundi S, Dolkas J . Reciprocal relationship between membrane type 1 matrix metalloproteinase and the algesic peptides of myelin basic protein contributes to chronic neuropathic pain. Brain Behav Immun. 2016; 60:282-292. PMC: 5214638. DOI: 10.1016/j.bbi.2016.11.003. View